Navigation Links
Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
Date:11/20/2012

SAN DIEGO, Nov. 20, 2012 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), a leading hemp industry innovator and its portfolio company CanChew Biotechnologies is pleased to announce that registration for their free product trial of CanChew gum was met with great enthusiasm. 

The offer was originally extended on Oct. 1 to 250 participants, on a first come/first served basis.  It was to include patients suffering from a variety of health issues who would share specific feedback regarding usage and experience. However, due to overwhelming response and a review of regulatory standards, the Company has chosen to reassess its vision for the offer.  It is now focused upon gaining market intelligence for upcoming product offerings. 

Under the updated guidelines, 500 individuals will receive the 30-day free sample of the CBD-based CanChew gum in exchange for their feedback on the appearance, branding and taste of the gum.

Participants can look forward to receiving a minimum one-month supply of the functional CBD gum, which contains approximately 7 milligrams of CBD per piece and will be blister packed in 8 and 32 count packages.  Three different versions of the gum varying in brand, appearance and taste will be randomly distributed and feedback for each specifically tracked. 

Ted Caligiuri, Medical Marijuana, Inc. President, is enthusiastic about this effort.  "We have a tremendous pool of participants for the CanChew free product trial.  The objective feedback they supply on appearance, branding and taste will be invaluable to the development and delivery of a quality product.  It will be instrumental in our preparations for our full blown national CanChew launch in early 2013."

Participants should look for several imminent email updates regarding how to implement their order and shipping.  The only cost involved will be a nominal shipping charge of $4.95 for product delivery
'/>"/>

SOURCE Medical Marijuana, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Prostate Cancer Medical Websites: Friend Or Foe?
2. Medical vital-sign monitoring reduced to the size of a postage stamp
3. Arecor Awarded Biomedical Catalyst Funding Towards £1.3 Million Project
4. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
5. Global Medical Image Analysis Software Market Worth $2.4 Billion by 2017
6. Nanofibrillar cellulose film to ease performing medical tests
7. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
8. Germany Prioritizes Medical Biotechnology with New Initiatives
9. University of Kentucky Medical Center Transplants States 1st SynCardia Total Artificial Heart Patient
10. Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
11. Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems Announces Successful Production of Hemp Harvesting for High Value CBD Oil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  Transwestern | RBJ today announces the ... office space for Shire a leading biopharmaceutical company, at Two ... | RBJ,s Robert Richards , president, and Brian ... for the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... Pipette.com has added the Eppendorf ... portfolio of Eppendorf products. , The Eppendorf Centrifuge 5424/5424 ... 5424/5424 R and receive the following:, , ... or Eppendorf Reference 2 ,     3 Free ...
(Date:1/22/2015)... Diagenode, Inc., a leading global provider ... complete solutions for epigenetics research, recently launched a ... need for manual processing. The new ChIPettor System ... histones or transcription factors and a semi-automated pipette ...
(Date:1/22/2015)... PRINCETON, N.J. , Jan. 22, 2015  Derma ... tissue regeneration company focused on advanced wound care, ... from placental tissues, have been added to the ... announcement increases the opportunity for the AMNIOEXCEL® and ...
Breaking Biology Technology:Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
... Be Free of the Side Effects Associated with ... CeNeRx BioPharma, Inc., a clinical stage company ... the central nervous system (CNS), today announced issuance ... compounds that selectively target peripheral cannabinoid receptors. ...
... , ... Rochester, New York (PRWEB) April 1, 2009 ... were used successfully in a clinical study to model the effect ... ,The repolarization biomarkers, captured on a continuous electrocardiogram, played a key ...
... March 31 Alseres Pharmaceuticals, Inc. (Nasdaq: ... of the Company,s independent registered public accounting firm ... explanatory paragraph regarding the Company,s ability to continue ... NASDAQ-traded companies to publicly announce if their Annual ...
Cached Biology Technology:CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors 2CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors 3iCardiac Applies Advanced Cardiac Safety Biomarkers in Clinical Study for Top Pharmaceutical Company 2Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K 2Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K 3
(Date:1/22/2015)...  Today, FreeWavz ( www.FreeWavz.com ), the developer of ... Fundable, https://www.fundable.com/freewavz . FreeWavz will be expanding ... meet customer demand. Logo - ... Invented by Dr. Eric ...
(Date:1/22/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a ... the recent success of the Wocket™ smart wallet at CES 2015 in ... was named as one of the "11 Hot Products at CES" in ... At CES So Far" by Newseveryday.com and "The top 10 gadgets from ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) ... Wearable Technologies Market and Applications, Opportunities, Industry Analysis, ... 2014-2020" report to their offering. , ... can be worn on the user,s body and ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... of the worlds leading marine biologists will gather in Auckland ... life from the poles to the tropics. This major meeting ... Marine Life, is being jointly hosted by the National Institute ... Auckland. The Census of Marine Life is ...
... Reserve Universitys School of Medicine have published in ... a natural product derived from the Amazon rainforest. ... of applications in various joint, skin and gastrointestinal ... publication revealed that Progrado, an extract from a ...
... 24, 2007 The vast majority of patients ... MitraClip device did not need mitral valve surgery ... from significantly improved function of the left ventricle ... presented this week at the Cardiovascular Research Foundations ...
Cached Biology News:Natural product discovery by Cleveland medical researchers blocks tissue destruction 2New data shows benefits of MitraClip for patients with mitral regurgitation 2New data shows benefits of MitraClip for patients with mitral regurgitation 3
Proliferin (C-14)...
... Rabbit polyclonal to Dideoxycytidine Dideoxycytidine is a ... effective in inhibiting retroviral activity. Immunogen: ... Specificity: The specificity of the ... of the moles of ddC to moles of ...
The Holten Safe 2010 Class II Biological Safety Cabinets provide the most ergonomical working condition of comfort while incorporating the latest technology for safety, efficiency and performance....
...
Biology Products: